Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Tanious Jubran N.President & COO | Tax withholding | F | $58K 7,244 sh | Mar 16, 2026 |
| 8 | McCulloch KevinSee Remarks | Option exercise | M | $200K 48.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 8 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $174K 6,348 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 8 | Pledger Thomas ChristopherCHIEF FINANCIAL OFFICER | Tax withholding | F | $56K 13.1K sh | Mar 16, 2026 traded Mar 15, 2026 |
| 8 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $309K 5,191 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 8 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $309K 5,191 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 8 | McCulloch KevinSee Remarks | Option exercise | M | $200K 48.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 6 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $130K 3,098 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 6 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $160K 8,456 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | Tanious Jubran N.President & COO | Grant or award | A | — 76.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | Tanious Jubran N.President & COO | Grant or award | A | — 16.4K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 5 | Ford William ACHIEF OPERATING OFFICER | Tax withholding | F | $42K 9,806 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 5 | McCulloch KevinSee Remarks | Option exercise | M | $15.76 4 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | McCulloch KevinSee Remarks | Option exercise | M | $15.76 4 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | Asmerom AmineChief Accounting Officer | Grant or award | A | — 75.0K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | Newcomb Matthew SChief Financial Officer | Grant or award | A | — 281.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | Hughes Edmond E. Jr.Ex VP & Chief HR Officer | Grant or award | A | — 7 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 5 | Chewning Eric D.EVP, Maritime Sys & Corp STR | Grant or award | A | — 7 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 5 | Chuang Patrick T.Senior VP, Memory Design | Option exercise | M | — 40.0K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 5 | Britt Christopher RDirector, Chief Executive Officer | Grant or award | A | — 900.6K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | Steves SeanSr VP & COO of SW Ops | Open-market sale · 10b5-1 plan | SELL | $8,702 97 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 3 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 6,348 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 3 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 1,754 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 3 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 2,985 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 2 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $216K 2,985 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 2 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $121K 4,125 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 1 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $84K 3,079 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 1 | Steves SeanSr VP & COO of SW Ops | Open-market sale · 10b5-1 plan | SELL | $17K 197 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 4,167 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 3,542 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 8,456 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $59K 4,167 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $36K 3,542 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $49K 1,754 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $6,856 6,348 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $7,038 253 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 56 | Nielson Brandon R.Director | NAKeystone Private Income Fund Open-market purchase | BUY | $10.00M 101.5K sh | Mar 13, 2026 traded Mar 1, 2026 |
| 50 | Dorosh DmitriyPrincipal Accounting Officer | Open-market sale | SELL | $1.14M 2,509 sh | Mar 13, 2026 traded Mar 13, 2026 |
| 48 | Helfert AdrianCIO, Multi-Asset Inv. | Open-market sale | SELL | $175K 10.8K sh | Mar 13, 2026 traded Feb 23, 2026 |
| 48 | Lockridge MatthewHead, U.S. Value Inv. | Open-market sale | SELL | $87K 5,379 sh | Mar 13, 2026 traded Feb 23, 2026 |